Ribosomal protection as a linezolid resistance mechanism in <i>Mycobacterium abscessus</i>
<i>Mycobacterium abscessus</i> has emerged as a significant pulmonary pathogen characterized by its resistance to most first-line antimycobacterial drugs. Recent investigations have highlighted the clinical efficacy of including the oxazolidinone antibiotic linezolid in <i>M. abscessus</i> combination therapies, despite moderate resistance frequently being observed in patient isolates. Even with the potential usefulness of linezolid, the mechanisms that drive linezolid resistance in <i>M. abscessus</i> remain poorly understood. In several bacterial pathogens, including <i>Mycobacterium tuberculosis</i>, ATP-binding cassette (ABC) family proteins of the F subtype (ABC-F) have been found to confer antibiotic resistance to ribosome-targeting antibiotics, including linezolid. Here, we identified an <i>M. abscessus</i> ABC-F protein, MAB_2736c, that causes specific resistance to antibiotics that bind the 50S ribosomal subunit, including linezolid, macrolides, and chloramphenicol. These results demonstrate that targeting ABC-F proteins could help combat intrinsic resistance to several ribosome-targeting antibiotics in mycobacteria.
Authors
- Kerry McGowen (ORCID: https://orcid.org/0000-0002-8451-4070)
- Mark R. Sullivan
- Dennis Nurjadi (ORCID: https://orcid.org/0000-0002-1278-5939)
- Samuel Zinga (ORCID: https://orcid.org/0000-0002-4633-8299)
- Tobias Funck
- Claudia M. Denkinger
- Eric J. Rubin
- Ian D. Wolf
Institutions
- Harvard University (US)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- University Hospital Schleswig-Holstein (DE)
- German Center for Infection Research (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Antimicrobial Agents and Chemotherapy
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1128/aac.01605-25
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00